1. HBW Insight
  2. >>Wellness
  3. >>Business
  4. >>Deals

Venture Life Acquires Helsinn Products As First-Half Sales Slide

 
• By Tom Gallen

Venture Life has snapped up two self-care medical devices and a dietary supplement in the oncology support category from Switzerland's Helsinn. The company also reported a double-digit drop in first-half sales.

Mergers and Acquisitions
• Source: Alamy

UK-based Venture Life Group PLC (VLG) has acquired three products positioned for oncology support from Helsinn Healthcare SA for CHF6.0m ($6.5m).

Two of the products – Gelclair and Xonrid – are registered as self-care medical devices but distributed through healthcare professionals, while the third, Pomi-T, is a dietary

The three acquired products are:

Gelclair - a muco-adhesive oral rinse gel used for the management of painful symptoms of oral mucositis, a side effect of some cancer therapies. Marketed in 40 countries.

Xonrid - a hyaluronic acid based topical gel used for the prevention and treatment of radiation induced dermatitis. Marketed in 21 countries

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

Haleon Utilizing AI To Develop Natural CHC Products

 
• By Tom Gallen

Haleon is partnering with San Francisco's Brightseed to utilize its AI technology to identify bioactive compounds in plants for use in consumer health products.

Opella Goes Solo Promising To ‘Redefine The Future Of Self-Care’

 
• By Tom Gallen

Private equity firm CD&R takes control of Opella while Sanofi retains a sizeable stake and nets €10bn.

Astaxanthin Specialist AstaReal Diversifies With Garlic Supplement For Heart Health

 
• By Tom Gallen

Swedish producer of antioxidant astaxanthin AstaReal has expanded its product offering with cardiovascular health focused-brand Kyolic.

Italy’s PharmaNutra Grows Presence In Americas And MENA

 
• By Tom Gallen

Iron supplements specialist PharmaNutra has penned distribution deals to take its products to additional markets across the Americas and the Middle East & North Africa.

More from Business

US Consumer Health Market People News: Niagen, INW, Hims & Hers, NOW, Tranont, More

 
• By Malcolm Spicer

Amazon executive moves Hims & Hers; INW Manufacturing adds IPA board member as CSO; USC Gerontology School dean joins Niagen advisory board; ‘Be You, NOW’ campaign during Women’s Health Month; direct seller Tranont expands advisory board; Vitamin Shoppe, sports nutrition brands support Team Red, White & Blue cross-US runners; and Powerade supports Morgan's Message.

C&D Divesting Flawless, Spinbrush Lines, Says Gummy Vitamin Brands Might Not Stick

 
• By Malcolm Spicer

C&D reports Q1 net sales dropped 2.4% to $1.48bn, below its guidance for around 1% growth. Its brands’ sales at retail and market share grew in the quarter, but “experienced slowing category growth in the US market” as retailers reduced inventory levels.

Herbalife Expects No ‘Material’ Impact From China Tariff, Recent Deals To Bring ‘New Era’ Of Growth

 
• By Malcolm Spicer

Herbalife expects little impact from increased tariffs on imports from China but strong boosts from acquiring Pro2col Health and Pruvit Ventures Inc. and 51% ownership of Link BioSciences.